Skip to content

Exagen Inc. XGN Earnings yield

Earnings yield at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
4.3%+0.5pp
Quest Diagnostics logo
Quest DiagnosticsDGX
4.8%0.0pp
Vor Biopharma logo
Vor BiopharmaVOR
-733.6%-1,389pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-24.9%-110pp
CareDx logo
CareDxCDNA
-0.9%-7.2pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.2%+1.2pp

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on trailing twelve months.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s earnings yield?
Exagen Inc. (XGN) reported earnings yield of -27.9% in Q1 2026.
How has Exagen Inc.'s earnings yield changed year-over-year?
Exagen Inc.'s earnings yield decreased by 15.8% year-over-year, from -24.1% to -27.9%.
What is the long-term trend for Exagen Inc.'s earnings yield?
Over 5 years (2020 to 2025), Exagen Inc.'s earnings yield has grown at a 13.1% compound annual growth rate (CAGR), from -7.8% to -14.5%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.